During Wednesday’s Morning trade, Shares of Ford Motor Co. (NYSE:F), gained 1.27% to $14.34.
Lincoln reveals a newly designed MKZ recently, focusing on areas most desired by today’s luxury midsize sedan customer – quality, performance and style.
“Our customers are looking for three attributes in a luxury midsize sedan – technologies that ease their everyday experience, a beautiful design that is crafted with attention to detail, and a vehicle with impressive power that makes it a pleasure to drive,” said Kumar Galhotra, president of Lincoln. “The new Lincoln MKZ elevates all of these attributes – and many more – to create a compelling entry in this large and highly competitive portion of the luxury market.”
The new Lincoln MKZ is designed to appeal to those who are looking for something different in the luxury market. From the placement of technology features such as the push-button gear shift to reimagined interior spaces counting the floating center console, drivers can relish in discovering an unpredictable experience based on intelligent function and beautiful form that offers, above all, an enjoyable drive.
The Lincoln Experience is brought to life through the available Lincoln-exclusive 3.0-liter GTDI V6 engine, in addition to intangible elements like the quiet cabin offered by the Active Noise Control system.
The Lincoln Motor Company is the luxury automotive brand of Ford Motor Company, committed to creating compelling vehicles with an exceptional ownership experience to match.
Ford Motor Company manufactures and distributes automobiles worldwide. The company operates through two sectors, Automotive and Financial Services. The Automotive sector develops, manufactures, distributes, and services vehicles, parts, and accessories. It offers vehicles primarily under the Ford and Lincoln brand names. This sector markets and sells its products through distributors and dealers, in addition to through dealerships to fleet customers, counting commercial fleet customers, daily rental car companies, and governments.
Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL), inclined 21.39% to $3.93, during its current trading session.
Anavex Life Sciences Corp., declares that it is moving forward with the development program for ANAVEX 2-73. Guidance received from the FDA confirms the Company’s strategy to advance ANAVEX 2-73 for the treatment of Alzheimer’s disease in a larger double-blinded, randomized, placebo-controlled Phase 2/3 trial.
“Working with a highly vulnerable patient population, the Company is proceeding in a rational, step-wise process. Armed with the necessary data from the Phase 2a study to optimally design future trials, we look forward to expanding our development program,” said Kristina M. Capiak, Vice President Regulatory Affairs of Anavex.
“The utilization of Adaptive Design and Population Pharmacokinetics/Pharmacodynamics (PK/PD) modeling is a major strength of the Phase 2a study. By implementing a different, innovative trial design for ANAVEX 2-73 in Alzheimer’s treatment, it is believed that this is more efficient than a conventional Phase 2 study since it is designed to reduce the risk of a Phase 3 trial failure, in addition to receiving the best quality information we can about ANAVEX 2-73,” said Christopher U. Missling, PhD, President and Chief Executive Officer of Anavex. “The advantage of having Population PK/PD data is of value for the development of ANAVEX 2-73 in Alzheimer’s disease and also for other potential CNS indications.”
Anavex Life Sciences Corp., a biopharmaceutical company, is engaged in the discovery and development of drugs for the treatment of Alzheimer’s disease, central nervous system diseases, and pain and various cancers. Its lead drug candidates comprise ANAVEX 2-73 and ANAVEX PLUS, a combination of ANAVEX 2-73 with donepezil (Aricept), which is in a Phase IIa clinical trial for the treatment of Alzheimers disease.
Finally, Micronet Enertec Technologies, Inc. (NASDAQ:MICT), surged 27.08%, and is now trading at $2.44.
Micronet Enertec Technologies, declared financial results for the third quarter ended September 30, 2015.
Third Quarter 2015 Review
- Total revenue reduced to $5.6 million for the third quarter of 2015, as contrast to $11.4 million in the third quarter of 2014. Sequentially, revenues reduced slightly from $5.7 million in the second quarter of 2015. Third quarter revenue was influenced by the shift of certain deliveries in our Aerospace & Defense division from the third quarter to the fourth quarter of 2015. Total revenue for the nine months ended September 30, 2015 was about $17 million, as contrast to $23.6 million for the same period in 2014.
- Gross profit margin was 20%, as contrast to 25% in the third quarter of 2014. The decline in overall gross margin was related to the shift in Aerospace & Defense deliveries, as detailed above. Gross profit of the MRM division was 27%, as contrast to 26% for the same period in 2014.
- Research and development (R&D) expense for the third quarter of 2015 was $485,000, or 8.7% of sales, contrast to $546,000, or 4.8% of sales, in the third quarter of 2014. On a sequential basis, R&D expense reduced 32%, as contrast to the second quarter of 2015.
- Selling, General and Administrative (SG&A) expense was $1.5 million, or 28% of sales, as contrast to $2.2 million, or 19% of sales, in the third quarter of 2014.
- Net loss attributed to MICT for the third quarter of 2015 was $1.2 million, or a loss of $0.22 per basic and diluted share, as contrast to a net loss of $0.5 million, or a loss of $0.09 per basic and diluted share, for the third quarter of 2014.
- The Company stated an operating loss of $1.2 million for the third quarter of 2015, as contrast to an operating loss of $0.2 million in the third quarter of 2014.
- At September 30, 2015, the Company stated cash and marketable securities totaling $10.7 million and working capital of $13.1 million.
Micronet Enertec Technologies, Inc. engages in the design, development, manufacture, integration, and marketing of rugged computers, tablets, and computer-based systems and instruments for the commercial, defense, and aerospace markets in the United States, Israel, and internationally.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.